As part of the systemic humoral response analysis in tumor-bearing mice, we determined the percentage of B (CD19+), plasmatic (CD138+), and plasmacytoid cells (CD19+/CD138+) from the spleen. This evidence concerns the gene CD19 and neoplasm.